Literature DB >> 2971418

Intra-arterial hepatic chemotherapy for liver malignancy.

S T Malik1, P F Wrigley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2971418      PMCID： PMC1833854          DOI： 10.1136/bmj.297.6646.434

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Effects of intra-arterial administration of nitrogen mustard.

Authors:  H R BIERMAN; R L BYRON; E R MILLER; M B SHIMKIN
Journal:  Am J Med       Date:  1950-04       Impact factor: 4.965

2.  Intraaterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma: a clinical and pharmacology report.

Authors:  M M Bern; W McDermott; B Cady; R A Oberfield; C Trey; M E Clouse; J L Tullis; L M Parker
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

3.  Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses.

Authors:  H S Chen; J F Gross
Journal:  Cancer Treat Rep       Date:  1980-01

Review 4.  Intraarterial hepatic infusion chemotherapy in metastatic liver cancer.

Authors:  R A Oberfield
Journal:  Semin Oncol       Date:  1983-06       Impact factor: 4.929

5.  Ambulatory pump infusion devices for hepatic artery infusion.

Authors:  J Lokich; W Ensminger
Journal:  Semin Oncol       Date:  1983-06       Impact factor: 4.929

6.  Tumor and liver drug uptake following hepatic artery and portal vein infusion.

Authors:  E R Sigurdson; J A Ridge; N Kemeny; J M Daly
Journal:  J Clin Oncol       Date:  1987-11       Impact factor: 44.544

7.  Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium.

Authors:  T Konno; H Maeda; K Iwai; S Maki; S Tashiro; M Uchida; Y Miyauchi
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

8.  Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study.

Authors:  T B Grage; P P Vassilopoulos; W W Shingleton; A V Jubert; E G Elias; J B Aust; S E Moss
Journal:  Surgery       Date:  1979-10       Impact factor: 3.982

9.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

10.  Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein.

Authors:  J A Ridge; J R Bading; A S Gelbard; R S Benua; J M Daly
Journal:  Cancer       Date:  1987-05-01       Impact factor: 6.860
  10 in total
  4 in total

1.  The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour.

Authors:  J A Goldberg; T Murray; D J Kerr; N Willmott; R G Bessent; J H McKillop; C S McArdle
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

2.  Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases.

Authors:  J A Goldberg; J A Thomson; M S Bradnam; J Fenner; R G Bessent; J H McKillop; D J Kerr; C S McArdle
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

3.  The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases.

Authors:  J A Goldberg; D J Kerr; D G Watson; N Willmott; C D Bates; J H McKillop; C S McArdle
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

4.  Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.

Authors:  W Y Lau; W T Leung; S Ho; N W Leung; M Chan; J Lin; C Metreweli; P Johnson; A K Li
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.